About Genomelabs Bio Private Limited
Data last updated: 09 January 2026
Genomelabs Bio Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It specialises in preventive health supplements, a part of the broader healthcare sector. Incorporated on 25 April 2016, the company has been in operation for over 10 years.
Registered with ROC Hyderabad under CIN U73100TG2016PTC109185.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹20 Cr. It is led by directors Nagaraju Pathapati and Ashok Kumar Desu.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: D.No.8 – 2 – 120/86/9/4/28 Plot No.28 Rao & Raju Colony Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.55 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 42 employees as per the latest available data.
The company is associated with 1 brand - Genomelabs. As per MCA filings, the company has open charges of ₹18.19 Cr and satisfied charges of ₹1.4 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomelabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressD.No.8 – 2 – 120/86/9/4/28 Plot No.28 Rao & Raju Colony Banjara Hills, Hyderabad, Telangana, India – 500034
-
IndustryHealthcare, Preventive Health Supplements
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Genomelabs Bio Private Limited
Genomelabs Bio Private Limited operates one associated brand: Genomelabs. These brands represent Genomelabs Bio Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Operates an online platform providing nutritional products and supplements. | genomelabs.com |
Competitors & Alternatives of Genomelabs Bio Private Limited
Brands and companies operating in the same space as Genomelabs Bio Private Limited include SastaSundar, HealthKart, Nutrabay and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
SastaSundar
|
An online marketplace for healthcare products is operated. | Kolkata, India, India | 2011 |
HealthKart
|
Health and fitness products are sold via an online platform. | Delhi, India, India | 2011 |
Nutrabay
|
Nutritional supplements are sold via an online platform. | Delhi, India, India | 2016 |
HyugaLife
|
Provider of an e-commerce platform that sells authentic health and wellness products | Mumbai, India, India | 2022 |
Bright LifeCare
|
Nutritional supplements and wellness products are manufactured and sold. | Gurugram, India, India | 2011 |
GetSupp
|
Health and fitness supplements are offered online by GetSupp. | Bengaluru, India, India | 2022 |
RichesM
|
Healthcare supplements are supplied online by RichesM. | India | 2021 |
Cora Health
|
Online supplier of medical and nutritional food | Bengaluru, India, India | 2020 |
Live Unique Life
|
Provides a digital platform for purchasing vitamins and health supplements. | Ahmedabad, India, India | 2020 |
Athlab
|
Provides clean label sports supplements using natural ingredients for fitness recovery. | New Delhi, India, India | 2023 |
Business Activity of Genomelabs Bio Private Limited
Genomelabs Bio Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Genomelabs Bio Private Limited
Genomelabs Bio Private Limited is audited by A MADHUSUDANA & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A MADHUSUDANA & CO | blur-value | blur-value | blur-value |
Board of Directors of Genomelabs Bio Private Limited
Genomelabs Bio Private Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Nagaraju Pathapati
Also directs:
Genomelabs India Private Limited, Pnr Infra India Private Limited
|
Managing Director | 25 Apr 2016 | 10 Years 2 Months | Current |
| Ashok Kumar Desu | Whole-Time Director | 26 Apr 2016 | 10 Years 2 Months | Current |
Financials of Genomelabs Bio Private Limited FY 2025 filings available
Genomelabs Bio Private Limited reported revenue of ₹14.55 Cr (up 155% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Genomelabs Bio Private Limited
As of FY 2023, Genomelabs Bio Private Limited's shareholding pattern shows 99.50% by promoters, 0.50% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Genomelabs Bio Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2025 | Others | ₹1.52 Cr | Open |
| 28 Aug 2024 | Others | ₹2.1 Cr | Open |
| 13 Oct 2021 | Others | ₹14.57 Cr | Open |
| 23 Feb 2017 | Others | ₹1.4 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Genomelabs Bio Private Limited
Genomelabs Bio Private Limited has a workforce of 42 employees as of Apr 06, 2024.
Employee Count & EPFO Data of Genomelabs Bio Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Genomelabs Bio Private Limited
GSTIN & GST Filing Data of Genomelabs Bio Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Genomelabs Bio Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Genomelabs Bio Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Genomelabs Bio Private Limited
MSME Payment Delays by Genomelabs Bio Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Genomelabs Bio Private Limited
Subsidiaries & Group Companies of Genomelabs Bio Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Genomelabs Bio Private Limited with ownership details.
MCA Filings & Documents of Genomelabs Bio Private Limited
MCA Filings & Documents of Genomelabs Bio Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Genomelabs Bio Private Limited
Frequently Asked Questions about Genomelabs Bio Private Limited
Genomelabs Bio Private Limited is an active private limited company in the healthcare sector based in Hyderabad, Telangana, India. It was incorporated on 25 April 2016 (10+ years old) and is registered under CIN U73100TG2016PTC109185. The company has 42 employees.
Genomelabs Bio Private Limited reported revenue of ₹14.55 Cr for FY 2025 (up 155.00% YoY).
The current directors of Genomelabs Bio Private Limited are:
- Naveen Kumar Kotla
- Nagaraju Pathapati
- Ashok Kumar Desu
The primary industry of Genomelabs Bio Private Limited is healthcare. The company specifically operates in preventive health supplements. The company is currently active in this sector.
Yes, Genomelabs Bio Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Genomelabs Bio Private Limited can be reached at the registered office: D.No.8 – 2 – 120869428 Plot No.28 Rao & Raju Colony Banjara Hills, Hyderabad, Telangana, India – 500034, or through the website genomelabs.com.